Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer

by Nir Peled, Koichi Yoshida, Murry W. Wynes, Fred R. Hirsch
Published 2009-11-01

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.

by Kenichi Suda, Leslie Rozeboom, Hui Yu, Kim Ellison, Christopher J Rivard, Tetsuya Mitsudomi, Fred R Hirsch
Published 2017-01-01

Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines

by Kenichi Suda, Leslie Rozeboom, Koh Furugaki, Hui Yu, Mary Ann C. Melnick, Kim Ellison, Christopher J. Rivard, Katerina Politi, Tetsuya Mitsudomi, Fred R. Hirsch
Published 2017-01-01

Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer

by Mengting Zhou, Jun Fan, Zhenyu Li, Pindong Li, Yajie Sun, Yuhui Yang, Xiaoshu Zhou, Jing Wang, Ye Wang, Huiwei Qi, Weijing Cai, Xiaofang Dai, Fred R. Hirsch
Published 2019-11-01

Ancestry-specific predisposing germline variants in cancer

by Ninad Oak, Andrew D. Cherniack, R. Jay Mashl, TCGA Analysis Network, Fred R. Hirsch, Li Ding, Rameen Beroukhim, Zeynep H. Gümüş, Sharon E. Plon, Kuan-lin Huang
Published 2020-05-01

Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer

by David Dora, Christopher Rivard, Hui Yu, Shivaun Lueke Pickard, Viktoria Laszlo, Tunde Harko, Zsolt Megyesfalvi, Elek Dinya, Csongor Gerdan, Gabor Szegvari, Fred R. Hirsch, Balazs Dome, Zoltan Lohinai
Published 2021-06-01

Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer

by David L. Rimm, Gang Han, Janis M. Taube, Eunhee S. Yi, Julia A. Bridge, Douglas B. Flieder, Robert Homer, Anja C. Roden, Fred R. Hirsch, Ignacio I. Wistuba, Lajos Pusztai
Published 2019-06-01

Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution

by David Dora, Christopher Rivard, Hui Yu, Paul Bunn, Kenichi Suda, Shengxiang Ren, Shivaun Lueke Pickard, Viktoria Laszlo, Tunde Harko, Zsolt Megyesfalvi, Judit Moldvay, Fred R. Hirsch, Balazs Dome, Zoltan Lohinai
Published 2020-09-01

Early detection of lung cancer by using an autoantibody panel in Chinese population

by Shengxiang Ren, Shucai Zhang, Tao Jiang, Yayi He, Zhiyong Ma, Hourong Cai, Xiaohong Xu, Yan Li, Weijing Cai, Jing Zhou, Xiaopeng Liu, Xuejun Hu, Jun Zhang, Hui Yu, Caicun Zhou, Fred R. Hirsch
Published 2018-02-01

Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer.

by Pierre P Massion, Yong Zou, Hasmet Uner, Porntip Kiatsimkul, Holly J Wolf, Anna E Baron, Tim Byers, Steinn Jonsson, Stephen Lam, Fred R Hirsch, York E Miller, Wilbur A Franklin, Marileila Varella-Garcia
Published 2009-06-01

A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

by Kristin L. Ayers, Meng Ma, Gaspard Debussche, David Corrigan, Jonathan McCafferty, Kyeryoung Lee, Scott Newman, Xiang Zhou, Fred R. Hirsch, Philip C. Mack, Jane J. Liu, Eric E. Schadt, Rong Chen, Shuyu D. Li
Published 2021-04-01

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

by Julie R. Brahmer, Ramaswamy Govindan, Robert A. Anders, Scott J. Antonia, Sarah Sagorsky, Marianne J. Davies, Steven M. Dubinett, Andrea Ferris, Leena Gandhi, Edward B. Garon, Matthew D. Hellmann, Fred R. Hirsch, Shakuntala Malik, Joel W. Neal, Vassiliki A. Papadimitrakopoulou, David L. Rimm, Lawrence H. Schwartz, Boris Sepesi, Beow Yong Yeap, Naiyer A. Rizvi, Roy S. Herbst
Published 2018-07-01